SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-001257
Filing Date
2022-01-05
Accepted
2022-01-05 07:30:40
Documents
43
Period of Report
2022-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221532d1_8k.htm   iXBRL 8-K 27978
2 EXHIBIT 99.1 tm221532d1_ex99-1.htm EX-99.1 45616
6 GRAPHIC tm221532d1_ex99-1img001.jpg GRAPHIC 528629
7 GRAPHIC tm221532d1_ex99-1img002.jpg GRAPHIC 281583
8 GRAPHIC tm221532d1_ex99-1img003.jpg GRAPHIC 319668
9 GRAPHIC tm221532d1_ex99-1img004.jpg GRAPHIC 260701
10 GRAPHIC tm221532d1_ex99-1img005.jpg GRAPHIC 544275
11 GRAPHIC tm221532d1_ex99-1img006.jpg GRAPHIC 181640
12 GRAPHIC tm221532d1_ex99-1img007.jpg GRAPHIC 265506
13 GRAPHIC tm221532d1_ex99-1img008.jpg GRAPHIC 316152
14 GRAPHIC tm221532d1_ex99-1img009.jpg GRAPHIC 351215
15 GRAPHIC tm221532d1_ex99-1img010.jpg GRAPHIC 318518
16 GRAPHIC tm221532d1_ex99-1img011.jpg GRAPHIC 347195
17 GRAPHIC tm221532d1_ex99-1img012.jpg GRAPHIC 323753
18 GRAPHIC tm221532d1_ex99-1img013.jpg GRAPHIC 561311
19 GRAPHIC tm221532d1_ex99-1img014.jpg GRAPHIC 315467
20 GRAPHIC tm221532d1_ex99-1img015.jpg GRAPHIC 137853
21 GRAPHIC tm221532d1_ex99-1img016.jpg GRAPHIC 167661
22 GRAPHIC tm221532d1_ex99-1img017.jpg GRAPHIC 215418
23 GRAPHIC tm221532d1_ex99-1img018.jpg GRAPHIC 221012
24 GRAPHIC tm221532d1_ex99-1img019.jpg GRAPHIC 234371
25 GRAPHIC tm221532d1_ex99-1img020.jpg GRAPHIC 346948
26 GRAPHIC tm221532d1_ex99-1img021.jpg GRAPHIC 355730
27 GRAPHIC tm221532d1_ex99-1img022.jpg GRAPHIC 342950
28 GRAPHIC tm221532d1_ex99-1img023.jpg GRAPHIC 341485
29 GRAPHIC tm221532d1_ex99-1img024.jpg GRAPHIC 316880
30 GRAPHIC tm221532d1_ex99-1img025.jpg GRAPHIC 282903
31 GRAPHIC tm221532d1_ex99-1img026.jpg GRAPHIC 312538
32 GRAPHIC tm221532d1_ex99-1img027.jpg GRAPHIC 284666
33 GRAPHIC tm221532d1_ex99-1img028.jpg GRAPHIC 290656
34 GRAPHIC tm221532d1_ex99-1img029.jpg GRAPHIC 261348
35 GRAPHIC tm221532d1_ex99-1img030.jpg GRAPHIC 147434
  Complete submission text file 0001104659-22-001257.txt   12908537

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vyne-20220105.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vyne-20220105_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vyne-20220105_pre.xml EX-101.PRE 22613
37 EXTRACTED XBRL INSTANCE DOCUMENT tm221532d1_8k_htm.xml XML 3708
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 22509443
SIC: 2834 Pharmaceutical Preparations